TNFSF11 and neoplasm: In human acute myeloid leukemia, activation of RANKL expressed by tumor cells leads to a dual inhibition of NK cells, through the secretion of immunomodulatory factors directly inhibiting NK cells and the upregulation of RANK expression by NK cells.